Literature DB >> 34175787

Consequences of post-translational modifications on amyloid proteins as revealed by protein semisynthesis.

Stuart P Moon1, Aaron T Balana1, Matthew R Pratt2.   

Abstract

Alterations to the global levels of certain types of post-translational modifications (PTMs) are commonly observed in neurodegenerative diseases. The net influence of these PTM changes to the progression of these diseases can be deduced from cellular and animal studies. However, at the molecular level, how one PTM influences a given protein is not uniform and cannot be easily generalized from systemic observations, thus requiring protein-specific interrogations. Given that protein aggregation is a shared pathological hallmark in neurodegeneration, it is important to understand how these PTMs affect the behavior of amyloid-forming proteins. For this purpose, protein semisynthesis techniques, largely via native chemical and expressed protein ligation, have been widely used. These approaches have thus far led to our increased understanding of the site-specific consequences of certain PTMs to amyloidogenic proteins' endogenous function, their propensity for aggregation, and the structural variations these PTMs induce toward the aggregates formed.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amyloids; Native chemical ligation; Neurodegenerative disease; Posttranslational modifications; Protein synthesis

Mesh:

Substances:

Year:  2021        PMID: 34175787      PMCID: PMC8585673          DOI: 10.1016/j.cbpa.2021.05.007

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.972


  100 in total

1.  The Alzheimer's disease related tau protein as a new target for chemical protein engineering.

Authors:  Malgorzata Broncel; Eberhard Krause; Dirk Schwarzer; Christian P R Hackenberger
Journal:  Chemistry       Date:  2012-01-09       Impact factor: 5.236

2.  One-pot total chemical synthesis of human α-synuclein.

Authors:  Bruno Fauvet; Sara M Butterfield; Jonas Fuks; Ashraf Brik; Hilal A Lashuel
Journal:  Chem Commun (Camb)       Date:  2013-10-18       Impact factor: 6.222

3.  Traceless purification and desulfurization of tau protein ligation products.

Authors:  Oliver Reimann; Caroline Smet-Nocca; Christian P R Hackenberger
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-17       Impact factor: 15.336

4.  Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.

Authors:  Mahmood Haj-Yahya; Hilal A Lashuel
Journal:  J Am Chem Soc       Date:  2018-05-21       Impact factor: 15.419

5.  Synthesis aided structural determination of amyloid-β(1-15) glycopeptides, new biomarkers for Alzheimer's disease.

Authors:  Peng Wang; Jonas Nilsson; Gunnar Brinkmalm; Göran Larson; Xuefei Huang
Journal:  Chem Commun (Camb)       Date:  2014-12-11       Impact factor: 6.222

6.  Extent of inhibition of α-synuclein aggregation in vitro by SUMOylation is conjugation site- and SUMO isoform-selective.

Authors:  Tharindumala Abeywardana; Matthew R Pratt
Journal:  Biochemistry       Date:  2015-01-21       Impact factor: 3.162

7.  Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.

Authors:  Sathish Kumar; Nasrollah Rezaei-Ghaleh; Dick Terwel; Dietmar R Thal; Mélisande Richard; Michael Hoch; Jessica M Mc Donald; Ullrich Wüllner; Konstantin Glebov; Michael T Heneka; Dominic M Walsh; Markus Zweckstetter; Jochen Walter
Journal:  EMBO J       Date:  2011-04-28       Impact factor: 11.598

Review 8.  Huntington disease.

Authors:  Gillian P Bates; Ray Dorsey; James F Gusella; Michael R Hayden; Chris Kay; Blair R Leavitt; Martha Nance; Christopher A Ross; Rachael I Scahill; Ronald Wetzel; Edward J Wild; Sarah J Tabrizi
Journal:  Nat Rev Dis Primers       Date:  2015-04-23       Impact factor: 52.329

9.  Expressed protein ligation: a general method for protein engineering.

Authors:  T W Muir; D Sondhi; P A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 10.  SUMOylation in Neurodegenerative Diseases.

Authors:  Andrea Princz; Nektarios Tavernarakis
Journal:  Gerontology       Date:  2019-09-10       Impact factor: 5.140

View more
  1 in total

Review 1.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.